secwatch.observer — SEC 8-K summary
======================================

Issuer:     International Stem Cell CORP (ISCO)
CIK:        0001355790
Form:       8-K
Filed at:   2022-04-29T23:59:59+00:00
Accession:  0001683168-22-003021
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

International Stem Cell appoints Dr. Russell Kern as principal financial officer; granted 1M options, salary $130K
--------------------------------------------------------------------------------

- Dr. Russell Kern appointed principal financial officer effective April 25, 2022.
- He continues as EVP and Chief Scientific Officer.
- Granted options to purchase 1,000,000 shares of common stock.
- Salary increased to $130,000 per year.
- Biographical information incorporated from 2022 Proxy Statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1355790/000168316822003021/0001683168-22-003021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1355790/000168316822003021/isco-8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-003021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer